509 related articles for article (PubMed ID: 20587671)
1. Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice.
Bégué RE; Perrin K
Pediatrics; 2010 Jul; 126(1):e40-5. PubMed ID: 20587671
[TBL] [Abstract][Full Text] [Related]
2. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States.
Payne DC; Staat MA; Edwards KM; Szilagyi PG; Gentsch JR; Stockman LJ; Curns AT; Griffin M; Weinberg GA; Hall CB; Fairbrother G; Alexander J; Parashar UD
Pediatrics; 2008 Dec; 122(6):1235-43. PubMed ID: 19047240
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.
Boom JA; Tate JE; Sahni LC; Rench MA; Hull JJ; Gentsch JR; Patel MM; Baker CJ; Parashar UD
Pediatrics; 2010 Feb; 125(2):e199-207. PubMed ID: 20083525
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States.
Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
Pediatr Infect Dis J; 2013 Mar; 32(3):278-83. PubMed ID: 23014356
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States.
Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
Pediatrics; 2010 Feb; 125(2):e208-13. PubMed ID: 20100757
[TBL] [Abstract][Full Text] [Related]
6. Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua.
Mast TC; Khawaja S; Espinoza F; Paniagua M; Del Carmen LP; Cardellino A; Sánchez E
Pediatr Infect Dis J; 2011 Nov; 30(11):e209-15. PubMed ID: 21768920
[TBL] [Abstract][Full Text] [Related]
7. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.
Buttery JP; Lambert SB; Grimwood K; Nissen MD; Field EJ; Macartney KK; Akikusa JD; Kelly JJ; Kirkwood CD
Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S25-9. PubMed ID: 21183837
[TBL] [Abstract][Full Text] [Related]
8. Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia.
Field EJ; Vally H; Grimwood K; Lambert SB
Pediatrics; 2010 Sep; 126(3):e506-12. PubMed ID: 20732946
[TBL] [Abstract][Full Text] [Related]
9. Routine laboratory testing data for surveillance of rotavirus hospitalizations to evaluate the impact of vaccination.
Patel MM; Tate JE; Selvarangan R; Daskalaki I; Jackson MA; Curns AT; Coffin S; Watson B; Hodinka R; Glass RI; Parashar UD
Pediatr Infect Dis J; 2007 Oct; 26(10):914-9. PubMed ID: 17901797
[TBL] [Abstract][Full Text] [Related]
10. Rotavirus live, oral, pentavalent vaccine.
Tom-Revzon C
Clin Ther; 2007 Dec; 29(12):2724-37. PubMed ID: 18201590
[TBL] [Abstract][Full Text] [Related]
11. Estimated burden of rotavirus-associated diarrhea in ambulatory settings in the United States.
Flores AR; Szilagyi PG; Auinger P; Fisher SG
Pediatrics; 2010 Feb; 125(2):e191-8. PubMed ID: 20100749
[TBL] [Abstract][Full Text] [Related]
12. Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002.
Charles MD; Holman RC; Curns AT; Parashar UD; Glass RI; Bresee JS
Pediatr Infect Dis J; 2006 Jun; 25(6):489-93. PubMed ID: 16732145
[TBL] [Abstract][Full Text] [Related]
13. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children.
Paulke-Korinek M; Rendi-Wagner P; Kundi M; Kronik R; Kollaritsch H
Pediatr Infect Dis J; 2010 Apr; 29(4):319-23. PubMed ID: 19935446
[TBL] [Abstract][Full Text] [Related]
14. Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq.
Ciarlet M; Schödel F
Vaccine; 2009 Dec; 27 Suppl 6():G72-81. PubMed ID: 20006144
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya.
Feikin DR; Laserson KF; Ojwando J; Nyambane G; Ssempijja V; Audi A; Nyakundi D; Oyieko J; Dallas MJ; Ciarlet M; Neuzil KM; Breiman RF
Vaccine; 2012 Apr; 30 Suppl 1():A52-60. PubMed ID: 22520137
[TBL] [Abstract][Full Text] [Related]
16. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine.
American Academy of Pediatrics Committee on Infectious Diseases
Pediatrics; 2007 Jan; 119(1):171-82. PubMed ID: 17200286
[TBL] [Abstract][Full Text] [Related]
17. RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine.
Chandran A; Santosham M
Expert Rev Vaccines; 2008 Dec; 7(10):1475-80. PubMed ID: 19053204
[TBL] [Abstract][Full Text] [Related]
18. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states.
Curns AT; Steiner CA; Barrett M; Hunter K; Wilson E; Parashar UD
J Infect Dis; 2010 Jun; 201(11):1617-24. PubMed ID: 20402596
[TBL] [Abstract][Full Text] [Related]
19. Sustained efficacy of the pentavalent rotavirus vaccine, RV5, up to 3.1 years following the last dose of vaccine.
Vesikari T; Karvonen A; Ferrante SA; Kuter BJ; Ciarlet M
Pediatr Infect Dis J; 2010 Oct; 29(10):957-63. PubMed ID: 20442684
[TBL] [Abstract][Full Text] [Related]
20. Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases.
Cortese MM; Tate JE; Simonsen L; Edelman L; Parashar UD
Pediatr Infect Dis J; 2010 Jun; 29(6):489-94. PubMed ID: 20354464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
